“We found that the most important components of both satisfaction and dissatisfaction with jobs were concerned with satisfying higher level psychological needs.”

Based on the MONET results, the lower cost of DRV/r monotherapy versus triple therapy in the UK would allow more patients to be treated for fixed budgets, while maintaining HIV RNA suppression at 50 copies/mL. If all patients meeting the inclusion criteria of the MONET trial in the UK were...

Background: In virologically suppressed patients, switching to darunavir/ritonavir (DRV/r) monotherapy maintains HIV RNA suppression, and could also lower treatment costs. Objective: The purpose of this analysis was to calculate the potential cost savings from the use of DRV/r monotherapy in the...